Generic competition and pharma patent strategies - a sequel

被引：0

|

作者：

Whitehead, Brian

Jackson, Stuart ^{[1
]}

Kempner, Richard ^{[2
]}

机构：

[1] Addleshaw Goddard, London, England

[2] Addleshaw Goddard, Intellectual Property, London, England

来源：

JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE | 2008年 / 3卷 / 12期

关键词：

D O I：

10.1093/jiplp/jpn187

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

引用

收藏

页码：799 / +

页数：2

相关论文

共 50 条

[41] To patent or not to patent? Consideration of the societal aspects of patenting across pharma-nutrition industries
Feddema, Jelle J.
van der Waal, Mark B.
Renes, Max J.
Claassen, Eric
van de Burgwal, Linda H. M.
[J]. PHARMANUTRITION, 2021, 16
[42] Strategies for maximizing patent protection during the progression from generic structures to optimized compounds.
Hart, D
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U622 - U622
[43] Firms invent new strategies to deflect generic competition and stem growing safety concerns
Ainsworth, Susan J.
[J]. CHEMICAL & ENGINEERING NEWS, 2007, 85 (49) : 17 - +
[44] HOECHST-PHARMA WITH NEW STRATEGIES
HAUTHAL, HG
[J]. NACHRICHTEN AUS CHEMIE TECHNIK UND LABORATORIUM, 1994, 42 (11): : 1154 - 1154
[45] A CADD-alog of strategies in pharma
Wendy A. Warr
[J]. Journal of Computer-Aided Molecular Design, 2017, 31 : 245 - 247
[46] Pharma strategies extend drug lives
Robertson, D
[J]. NATURE BIOTECHNOLOGY, 1999, 17 (03) : 220 - 221
[47] A CADD-alog of strategies in pharma
Warr, Wendy A.
[J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2017, 31 (03) : 245 - 247
[48] Cosidering Bio/Pharma Reformulation Strategies
Thomas, Felicity
[J]. Pharmaceutical Technology, 2021, 45 (10) : 30 - 32
[49] Pharma strategies extend drug lives
Debra Robertson
[J]. Nature Biotechnology, 1999, 17 : 220 - 221
[50] Session 1: Strategies to engage pharma
Frank, Richard
[J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (06) : 22N - 23N

← 1 2 3 4 5 →